What podcasts say about BPC-157
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about BPC-157
26 statements · 15 positive · 5 negative · 2 mixed · 4 neutral
BPC-157 should be approved because it is effective for soft-tissue injuries.
“BPC-157, I think, would be an easy one to approve. That's the best one, I think, for soft tissue injuries.”
Open the episode · JRE MMA Show #186 with Sean SharafListen at 1:07:21
BPC-157 helps fighters recover without enhancing athletic performance.
“BPC-157 will help them recover, and it's not gonna make them a super athlete.”
Open the episode · JRE MMA Show #186 with Sean SharafListen at 1:08:43
Huberman reports shoulder pain disappeared after two small BPC injections.
“I'm going to just put 2 injections of BPC in there. So 2 injections of maybe 100 or 200 micrograms, tiny amounts, right? Um, gone.”
Open the episode · “This Is The Culmination Of Everything I Know” - Dr Andrew Huberman #1150Listen at 1:45:44
A retrospective analysis found three adverse events among 16 million BPC-157 patients.
“We did a retrospective analysis of 16 million patients that were on BPC-157. Out of that, we found 3 adverse events.”
Open the episode · Best Peptides, Stem Cells, Testosterone & Exercise Hacks - Biohacking Roundtable - #1148Listen at 1:15:47
BPC-157 may accelerate healing but could promote tumor vascularization.
“it does seem to accelerate healing across the board, but the concern is you could vascularize tumors.”
Open the episode · Andrew Huberman: My Exact Routine To Optimize Brain & Body, I Do All Of These Every Day!Listen at 1:09:03
BPC-157 may promote tumor vascularization.
“the concern is you could vascularize tumors.”
Open the episode · Andrew Huberman: The Real Reason You Can't Get Deep Sleep & Wake Up ExhaustedListen at 1:09:05
Animal studies of BPC-157 report cartilage, fibroblast, blood-vessel, and nerve-growth effects.
“The animal data on BPC are really impressive. Cartilage regrowth, fibroblast migration, angiogenesis, nerve regrowth.”
Open the episode · #876: Dr. Andrew Huberman — Peptides, Performance, and ProtocolsListen at 1:11:22
BPC-157 lacks published human clinical trials.
“There's not a single published human trial”
Open the episode · #876: Dr. Andrew Huberman — Peptides, Performance, and ProtocolsListen at 1:11:32
BPC-157 can promote angiogenesis.
“BPC157 has this next to it. It will cause angiogenesis.”
Open the episode · #876: Dr. Andrew Huberman — Peptides, Performance, and ProtocolsListen at 1:24:41
BPC-157 is prohibited for Olympians but permitted for ordinary people.
“BPC157 is banned for Olympians. Not for a regular person. Regular people can take it.”
Open the episode · #2514 - Cameron HanesListen at 2:36:15
BPC-157 taken two years earlier could not have helped win Hanes's marathon.
“there's no chance that helped you win a marathon two years later”
Open the episode · #2514 - Cameron HanesListen at 2:42:22
BPC157 is a 15-amino-acid fragment humans do not naturally produce.
“BPC157 is 15amino acids from that giant peptide. We don't naturally make BPC157.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 7:31
BPC157 accelerated healing in multiple injured-mouse models.
“they'd have faster healing times”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 11:51
BPC157 increases VEGF signaling and blood-vessel formation in experimental models.
“You'll get more VEGF signaling. So that's the vascular endothelial growth factor. So get more blood vessels androgenesis being formed”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 16:28
BPC157 preserved or improved wound healing despite corticosteroid treatment in mice.
“When BPC was administered, the healing was either the same or even better.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 17:01
BPC157 prevented alcohol-withdrawal symptoms in an animal model.
“they got BPC and they didn't have the withdrawal symptoms.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 18:42
Some users report oral BPC157 blunts Adderall effects.
“it seems like it's blunting their Adderall”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 19:06
Animals tolerated BPC157 doses up to approximately 1,000 times typical doses.
“they've injected animals with, you know, a thousand times the dose of BPC with no real adverse effects.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 20:13
Oral and rectal BPC157 appears not to enter systemic circulation.
“orally administered or rectally administered BPC doesn't seem to go systemic.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 21:52
A small phase-two trial found a positive ulcerative-colitis signal for BPC157.
“in the phase 2 trial, it was very small, like 40 patients. There was at least a positive signal on the ulcerative colitis.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 23:13
Animal studies have not shown a cancer signal for BPC157.
“There is no signal from the Animal Literature on BPC157 for, you know, cancers.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 43:03
Some users report worsening hematomas with BPC157, consistent with VEGF effects.
“on Reddit you'll find signals of hematomas getting worse. Which makes sense with the, with the VEGF pathway.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 44:05
BPC157 could potentially treat gastric ulcers in intensive-care patients, pending evidence.
“if we knew that it would work, I would love to give them an infusion of BPC157.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 45:11
Researchers should conduct a phase-three BPC157 trial for ulcerative colitis.
“I would say to complete the phase one, phase two on the ulcerative colitis, do that phase three trial on proving that it has benefits for ulcerative colitis.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 50:06
BPC157 might shorten post-surgical ACL recovery from twelve months to six.
“can it further accelerate the healing from an ACL surgery so you come back in six months rather than 12 months? That's the big question.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 53:29
BPC157 may be highly beneficial, ineffective, or harmful; current data cannot distinguish these outcomes.
“Either BPC is as amazing as we think it is and it's unfortunate that millions of people don't have access to it, or BBC is actually either ineffective or harmful to people”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 57:37
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.